Drugs / Aldosterone
Aldosterone
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00700479 | Jan 2006 → Jun 2008 | — | Yale University | Completed | No outcome recorded |
| Phase not applicable1 trial · 1 missed | ||||||
| — | NCT00732160 | Sep 2008 → Sep 2012 | diabetes mellitus | Vanderbilt University | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07281014 Comparator | Jan 2026 → Aug 2027 expected | heart failure | Yale University | Recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aldosterone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07281014 ↗ |
| Known as | Aldosterona | ChEMBL registry synonym — accepted as the source's own label CHEMBL273453 ↗ |
| Known as | NSC-73856 | ChEMBL registry synonym — accepted as the source's own label CHEMBL273453 ↗ |
| Modality | Small molecule | — CHEMBL273453 ↗ |
| Route | Intravenous | “IV Aldosterone infusion” NCT07281014 ↗ |